The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis

Author(s): Assuero Giorgetti*, Dario Genovesi, Michele Emdin

Journal Name: Current Radiopharmaceuticals

Volume 14 , Issue 3 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Endocarditis, myocarditis and pericarditis are a heterogeneous group of phenotypic syndromes where the culprit area of inflammation is the heart. Inflammation may be determined by an infective agent, toxins, drugs or an activated immune system. Clinical manifestations can be subtle and diagnosis remains a challenge for cardiologists, requiring high level of suspicion and advanced multimodal cardiac imaging to avoid life-threatening consequences. The purpose of this review is to report the recent advances of PET/CT imaging with 18FDG in helping the management of patients affected by inflammatory heart disease. Two independent reviewers searched in PubMed articles published before or in June 2019 and final decisions on the inclusion of references were done in consensus with a third reviewer. At the end of the selection process 23/206 articles on “cardiac inflammation”; 26/235 articles on “endocarditis”, “prosthetic heart valve”, “pacemaker”, “implantable cardiac device”; 7/103 articles on “myocarditis”; 13/330 articles on sarcoidosis” and 2/19 articles on “pericarditis” were included. Compared with the conventional methods, molecular imaging has the advantage to non-invasively and directly trace the inflammatory process, and to identify earlier the presence and the extent of intra-cardiac and extra-cardiac involvement, to enable quantification of disease activity, guide therapeutic interventions, and monitor treatment success.

Keywords: PET/CT, inflammatory, molecular imaging, cardiologists, myocarditis.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 3
Year: 2021
Page: [259 - 272]
Pages: 14
DOI: 10.2174/1874471013666200422102406
Price: $95

Article Metrics

PDF: 36